Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Top Cited Papers
- 6 January 2020
- journal article
- research article
- Published by Elsevier BV in Annals of Oncology
- Vol. 31 (1), 17-29
- https://doi.org/10.1016/j.annonc.2019.10.010
Abstract
No abstract availableKeywords
Funding Information
- ESMO
- Roche
- Roche
- Bayer
- Celgene
- Sandoz
- Gilead Sciences
- Gilead Sciences
- Roche
- Celgene
- Gilead Sciences
- Roche
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Pfizer
- Celgene
- Celgene
- Novartis
- AstraZeneca
- Merck, Sharp and Dohme
- Roche
- Gilead Sciences
- Gilead Sciences
- Roche
- Bayer
- Celgene
- Roche
- Sanofi
- Roche
- Celgene
- Bristol-Myers Squibb
- Celgene
- Roche
- Bayer
- Amgen
This publication has 74 references indexed in Scilit:
- Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literatureBlood, 2013
- Significant efficacy of 2-chlorodeoxyadenosine± rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-upAnnals of Oncology, 2013
- Overexpression of miR-142-5p and miR-155 in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Resistant to Helicobacter pylori EradicationPLOS ONE, 2012
- Second Cancers and Residual Disease in Patients Treated for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma by Helicobacter pylori Eradication and Followed for 10 YearsGastroenterology, 2012
- A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomasBritish Journal of Haematology, 2009
- Chlorambucil versus observation after anti‐Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trialBritish Journal of Haematology, 2009
- Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide studyEuropean Journal of Cancer, 2008
- Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteriaLeukemia, 2007
- Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT typeBlood, 2003
- Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2001